25 unknown. 25 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 25 | Unknown 25 |
Follow Pneumonia: new trials by email Literature Review of Pneumonia trials Research Report on Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study) INAVAC (Vaksin Merah Putih - UA- SARS CoV-2 (Vero Cell Inactivated) 5 μg - COVID-19 Pandemic, COVID-19 Vaccines | Early Phase 1 | Unknown | Dr. Soetomo General Hospital | 400 | 2024-01-29 | 2024-02-14 |
| UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects INAVAC (Vaksin Merah Putih - UA- SARS CoV-2 (Vero Cell Inactivated) 5 μg - COVID-19 Pandemic, COVID-19 Vaccines | Early Phase 1 | Unknown | Dr. Soetomo General Hospital | 250 | 2023-09-19 | 2024-02-22 |
| The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002 LYB002V14, LYB002V14A, LYB002CA - COVID-19 | Early Phase 1 | Unknown | Guangzhou Patronus Biotech Co., Ltd. | 210 | 2023-04-25 | 2023-07-03 |
| Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Exosomes in Treating Chronic Cough After COVID-19 MSC-derived exosomes - Long COVID-19 Syndrome | Early Phase 1 | Unknown | Huazhong University of Science and Technology | 80 | 2023-02-15 | 2023-04-14 |
| A Clinical Study on Safety and Effectiveness of Mesenchymal Stem Cell Exosomes for the Treatment of COVID-19. Extracellular Vesicles from Mesenchymal Stem Cells - COVID-19 Pneumonia | Early Phase 1 | Unknown | First Affiliated Hospital of Wenzhou Medical University | 240 | 2023-01-23 | 2023-04-07 |
| Yinhu Qingwen Granule in the Treatment of Viral Pneumonia Yinhu Qingwen Granules - Viral Pneumonia | Early Phase 1 | Unknown | Zhong Wang | 60 | 2022-12-01 | 2022-11-15 |
| A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5 V-01/V-01-B5, V-01-351/V-01-B5, V-01 - COVID-19 Pandemic | Early Phase 1 | Unknown | Livzon Pharmaceutical Group Inc. | 48 | 2022-09-16 | 2022-11-07 |
| UNAIR Inactivated COVID-19 Vaccine as Heterologue Booster (Immunobridging Study) Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg, CoronaVac Biofarma COVID-1 9 Vaccine 3 µg - COVID-19 Pandemic, COVID-19 Vaccines | Early Phase 1 | Unknown | Dr. Soetomo General Hospital | 350 | 2022-09-05 | 2023-06-26 |
| Exploratory Clinical Study to Evaluation of the Safety and Immunogenicity of Bivalent Vaccine V-01D-351 V-01D-351, CoronaVac - COVID-19 Pandemic | Early Phase 1 | Unknown | Livzon Pharmaceutical Group Inc. | 40 | 2022-08-15 | 2022-10-19 |
| A Phase Ia Clinical Study to Evaluate the Safety, Tolerability, PK and Immunogenicity of YBSW015 in Healthy Subjects YBSW015 injection - Coronavirus Disease 2019 | Early Phase 1 | Unknown | Yabao Pharmaceutical Group | 40 | 2022-07-01 | 2022-05-11 |
| Paxlovid in the Treatment of COVID-19 Patients With Uremia Paxlovid, standard-of-care - COVID-19, Uremia | Early Phase 1 | Unknown | Ruijin Hospital | 40 | 2022-06-01 | 2022-05-23 |
| The Immunogenicity and Safety Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB001 LYB001, CoronaVac - COVID-19, Vaccine Reaction | Early Phase 1 | Unknown | Guangzhou Patronus Biotech Co., Ltd. | 120 | 2022-05-14 | 2023-07-03 |
| Testing a Mindfulness/Acceptance-Based Smartphone App for Nurses Impacted by the COVID-19 Pandemic Mindfulness/Acceptance-Based Smartphone App (MABSA) - Posttraumatic Stress Disorder | Early Phase 1 | Unknown | University of Nevada, Las Vegas | 60 | 2022-01-01 | 2022-01-05 |
| Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals Hydroxychloroquine Sulfate, Bromhexine 8 MG - Hydroxychloroquine, Antimalarials | Early Phase 1 | Unknown | Instituto Nacional de Rehabilitacion | 214 | 2021-02-01 | 2021-06-29 |
| Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease Ophtamesone - Clinical Trial | Early Phase 1 | Unknown | University Of Anbar | 250 | 2020-08-01 | 2020-09-30 |
| Remdesivir in COVID-19 Lahore General Hospital Remdesivir - SARS-CoV Infection | Early Phase 1 | Unknown | Lahore General Hospital | 30 | 2020-06-01 | 2020-09-25 |
| Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients recovered covid 19 patients plasma - Covid19 | Early Phase 1 | Unknown | South Valley University | 30 | 2020-05-29 | 2020-08-28 |
| Convalescent Plasma Therapy for COVID-19 Patients convalescent plasma - SARS-CoV Infection | Early Phase 1 | Unknown | Lahore General Hospital | 20 | 2020-05-01 | 2020-12-08 |
| Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19 Mesenchymal Stem Cells derived from Wharton Jelly of Umbilical cords - ARDS, Human, Covid-19 | Early Phase 1 | Unknown | Instituto de Medicina Regenerativa | 9 | 2020-04-16 | 2024-03-06 |
| Anti COVID-19 Convalescent Plasma Therapy anti-SARS-CoV-2 convalescent plasma - COVID 19 | Early Phase 1 | Unknown | Orthosera Kft. | 20 | 2020-04-14 | 2021-02-25 |
Showing 20 of 25. Sign in to see all of them.
COVID-19 (21) · Pneumonia, Viral (2) · Severe Acute Respiratory Syndrome (2) · Anosmia (1) · Chronic Cough (1) · Coronavirus Infections (1) · Idiopathic Pulmonary Fibrosis (1) · Ischemic Stroke (1) · Lung Diseases, Interstitial (1) · Pneumonia, Pneumocystis (1) · Pneumonia, Ventilator-Associated (1) · Post-Acute COVID-19 Syndrome (1) · Pulmonary Alveolar Proteinosis (1) · Pulmonary Disease, Chronic Obstructive (1) · Respiratory Distress Syndrome (1)
Infections (25) · Lung Diseases (25) · Respiratory Tract Diseases (25) · Respiratory Tract Infections (25) · Virus Diseases (23) · Coronaviridae Infections (22) · Nidovirales Infections (22) · RNA Virus Infections (22) · Coronavirus Infections (21) · Pneumonia, Viral (21) · Pathological Conditions, Signs and Symptoms (4) · Disease Attributes (3) · Pathologic Processes (3) · Chronic Disease (2)
vaksin merah putih - UA SARS-CoV-2 COVID-19 vaccine (3) · sinovac COVID-19 vaccine (2) · Amikacin (1) · Atorvastatin (1) · Bromhexine (1) · Hydroxychloroquine (1) · Immunization, Passive (1) · Mindfulness (1) · Saline Solution (1) · Standard of Care (1) · nirmatrelvir and ritonavir drug combination (1) · remdesivir (1)
Dr. Soetomo General Hospital (3) · Guangzhou Patronus Biotech Co., Ltd. (2) · Lahore General Hospital (2) · Livzon Pharmaceutical Group Inc. (2) · Black Tie Medical, Inc. (1) · CAR-T (Shanghai) Biotechnology Co., Ltd. (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · First Affiliated Hospital of Wenzhou Medical University (1) · Huazhong University of Science and Technology (1) · Instituto Nacional de Rehabilitacion (1) · Instituto de Medicina Regenerativa (1) · Orthosera Kft. (1) · Ruijin Hospital (1) · Shanghai Minhang Central Hospital (1) · South Valley University (1)
China (8) · Indonesia (3) · Mexico (2) · Pakistan (2) · Belgium (1) · Egypt (1) · Hungary (1) · Iraq (1) · United States (1)
Muhammad Irfan Malik, FCPS (2) · Xiaolan Yong, Bachelor (2) · Dominicus Husada, MD (1) · Jesus Perez (1) · Jihui Du, PhD (1) · Juan Parcero (1) · Julio Granados-Montiel, MD, PhD (1) · Liu ChunYan, MD (1) · Raid M Al-Ani, FIBMS (ENT) (1) · Robert W Alexander, MD (1) · Xiaoying Huang, Docter (1)
PMID 18945956, PMID 21340319, PMID 24013700, PMID 25321315, PMID 25900158, PMID 26492219, PMID 27146253, PMID 27183377, PMID 28621712, PMID 32020029, PMID 32091533, PMID 32094336, PMID 32109013, PMID 32142651, PMID 32150618, PMID 32167747, PMID 32228809, PMID 32294342, PMID 32379955, PMID 32475230, PMID 32619759, PMID 33059771, PMID 33108255, PMID 33155953, PMID 33232211, PMID 33296901, PMID 33301246, PMID 33306989, PMID 33323376, PMID 33353987, PMID 33378609, PMID 33519466, PMID 33558079, PMID 33619260, PMID 33686059, PMID 33767468, PMID 33839489, PMID 33846611, PMID 34013969, PMID 34037666, PMID 34246358, PMID 34344672, PMID 34354082, PMID 34750163, PMID 34817198, PMID 34914868, PMID 35015054, PMID 35067909, PMID 35180408, PMID 36062970